One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
A novel approach to boost drug development in paediatric oncology
Sam Daems, Hilde Stevens, Mathias Dewatripont, Hans-Georg Eichler & Michel Goldman
doi : 10.1038/d41573-023-00136-3
Volume 22 Issue 10, October 2023
FDA approves first oral drug for postpartum depression, but rejects it for major depressive disorder
Asher Mullard
FDA approves first GPRC5D × CD3-targeted bispecific for multiple myeloma
Asher Mullard
The next-generation CAR-T therapy landscape
Malvika Verma1 , Kyle Obergfell2 , Shana Topp3 , Val Panier3 & John Wu
Investigating the origins of recent pharmaceutical innovation
Alexander Schuhmacher, Markus Hinder, Alexander Dodel, Oliver Gassmann & Dominik Hartl
Clipping cell-surface mucins in cancer by targeted degradation
Alex Eccleston
A step closer to in vivo editing of haematopoietic stem cells
Katie Kingwell
AAV-based in vivo gene therapy for neurological disorders
Qinglan Ling, Jessica A. Herstine, Allison Bradbury & Steven J. GrayÂ
Antimalarial drug discovery: progress and approaches
Jair L. Siqueira-Neto, Kathryn J. Wicht, Kelly Chibale, Jeremy N. Burrows, David A. Fidock & Elizabeth A. WinzelerÂ
Strategies to therapeutically modulate cytokine action
Warren J. Leonard & Jian-Xin LinÂ
Trustworthy AI for safe medicines
Jens-Ulrich Stegmann, Rory Littlebury, Markus Trengove, Lea Goetz, Andrew Bate & Kim M. BransonÂ
